In two leading global markets, China and India, both these markets are exhibiting compelling medical acceptance of the Pressure Right disposable wrist strip as a new preventive remedy. It targets and blocks the occurrences of nausea and/or vomiting without the use of drugs.
The use of Pressure Right® has demonstrated one of the highest clinical ratings in nausea and vomiting prevention when used in combination with antiemetic drug therapy with no adverse effects.
Pressure Point Inc., a global medical device company is proud to announce that Health Canada has granted the company an establishment license for its Pressure Right® low-risk, Class 1 (Rx) antiemetic medical device for anesthesia use in hospitals.
In its December 2012 issue, the Outpatient Surgery Magazine’s product news section introduces Pressure Right®, the longer-acting perioperative, (Rx) antiemetic prophylaxis medical device to its readers. This device is a new breakthrough for reducing the high incidence of postdischarge nausea and vomiting (PDNV) of more than 35% at the end of the second postoperative day following discharge from ambulatory surgery for those patients receiving general anesthesia.
A new effective perioperative, antiemetic medical device has been developed by Pressure Point Inc., a global medical device company and Laminin Medical Products, an FDA registered establishment. Both companies jointly announcing a long-term manufacturing agreement in which Laminin will produce Pressure Right®, a new FDA-cleared (Rx) disposable, antiemetic innovation device, which uses advanced acupressure technology to enhance the management of nausea/and or vomiting following surgery.
Pressure Point Inc., a developer of medical devices has reached a 10-year distribution agreement promoting U.S. manufacturing jobs with Wuhan Health New Concept Medicine Co., Ltd in Wuhan, China, to distribute the company’s Pressure Right® disposable, acupressure-based antiemetic solution wrist strip, through their established distributor network throughout mainland China. This agreement is to take effect immediately with SinoCure LLC based in Beijing, China handling the registration process for Pressure Right®.
Among the latest discoveries in preventive care is a FDA-cleared antiemetic (non-drug) disposable acupressure wrist strip under the brand name Pressure Right®. This product empowers surgery patients to respond more favorably against PONV occurrences and because of improved patient satisfaction there is less demands placed on PACU nurses to treat PONV episodes.
Anesthesiologists across the nation appear to be responding to several key shortage factors that are influencing their acceptance of alternative antiemetic non-drug methods. Pressure Point Inc., an early growth healthcare company with a growing customer base, is experiencing significant clinical interest for its popular stay-enhanced (Pressure Right®) 72 hour (Rx) antiemetic (non-drug) acupressure disposable wrist strip from anesthesiologists associated with major hospitals and surgery centers across the country.
Pressure Point Inc. has developed an effective 72 hour low-cost, FDA Market Cleared (Rx) dermal device, which uses an advanced acupressure approach for longer-acting prophylactic results in reducing the occurrences of postoperative nausea and vomiting (PONV). The refinements associated with the non-invasive, Pressure Right® stimulation device, are such that they complement each other to bring about an enhancement of prevention of nausea and vomiting following surgery. Pressure Right® is the first of its (patent-pending) type to provide up to 72 hours of clinically proven enhanced effectiveness in PONV management.
Pressure right emetic-management device provides 72-hour effective prophylaxis of postoperative nausea and vomiting for $12 1/2 cents per hours, $2. 98 per day.
According to evidence-based research, too many patients still experience PONV following surgery, despite the use of antiemetic prophylactic drug combinations alone.
Peer-reviewed published study finds adjunctive use of Pressure Right Acupressure Device enhanced the efficacy of the most commonly used prophylactic antiemetic drug combination.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right